GWRS:NASDAQGlobal Water Resources, Inc. Analysis
Data as of 2026-04-07 - not real-time
$7.67
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Global Water Resources is trading at $7.67, just above its 20‑day SMA (7.52) but still below the 50‑day (8.31) and 200‑day (9.30) averages, confirming a bearish trend. The RSI sits at 45, indicating neither overbought nor oversold conditions, while the MACD histogram is marginally positive, hinting at a tentative short‑term bounce that may be short‑lived. Volatility is extreme at 53.9% over the past 30 days, and volume is on a downtrend, raising concerns about price stability. Valuation metrics are starkly misaligned: a trailing PE of 69.7 versus an industry average of 22.7, and a DCF‑derived fair value of $2.58, suggest the stock is significantly overvalued. The dividend yield of 3.88% looks attractive, but a payout ratio of 276% flags unsustainability.
Fundamentally, the company posted modest 2.2% revenue growth to $55.8 M, with a healthy gross margin (71.8%) but thin operating (2.65%) and profit margins (5.3%). Free cash flow is deeply negative (-$53.9 M) despite positive operating cash flow, and leverage is high with a debt‑to‑equity ratio of 159.7 and net debt far exceeding cash. Recent earnings calls highlighted continued capital‑intensive expansion in Arizona, but the financial strain and regulatory exposure in a single geographic market amplify risk. Overall, the combination of technical weakness, inflated valuation, and fragile fundamentals suggests caution.
Fundamentally, the company posted modest 2.2% revenue growth to $55.8 M, with a healthy gross margin (71.8%) but thin operating (2.65%) and profit margins (5.3%). Free cash flow is deeply negative (-$53.9 M) despite positive operating cash flow, and leverage is high with a debt‑to‑equity ratio of 159.7 and net debt far exceeding cash. Recent earnings calls highlighted continued capital‑intensive expansion in Arizona, but the financial strain and regulatory exposure in a single geographic market amplify risk. Overall, the combination of technical weakness, inflated valuation, and fragile fundamentals suggests caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below longer‑term moving averages
- High short‑term volatility and decreasing volume
- Overvalued relative to peers and DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Stable regulated revenue base
- Dividend yield remains appealing
- Continued cash‑flow pressure and high leverage
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Unsustainable dividend payout
- Persistent negative free cash flow
- Elevated debt levels limiting growth opportunities
Key Metrics & Analysis
Financial Health
Revenue Growth2.20%
Profit Margin5.30%
P/E Ratio69.7
ROE4.41%
ROA1.01%
Debt/Equity159.66
P/B Ratio2.5
Op. Cash Flow$20.2M
Free Cash Flow$-53866000
Industry P/E22.7
Technical Analysis
TrendBearish
RSI45.3
Support$7.12
Resistance$8.03
MA 20$7.52
MA 50$8.31
MA 200$9.30
MACDBullish
VolumeDecreasing
Fear & Greed Index77.8
Valuation
Fair Value$2.58
Target Price$10.85
Upside/Downside41.46%
GradeOvervalued
TypeValue
Dividend Yield3.88%
Risk Assessment
Beta0.51
Volatility53.91%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.